Table 2.

Improvement of clinical and laboratory manifestations in 6 and 12 months. Values are n (%) unless otherwise specified.

Variables	Time	Nonrenal, n = 72	Renal, n = 108
CNS	Baseline	11	7
	6 mos	8 (72.7)	3 (42.9)
	12 mos	8 (72.7)	6 (85.7)
Vasculitis	Baseline	2	6
	6 mos	2 (100)	6 (100)
	12 mos	1 (50)	6 (100)
MSK manifestations	Baseline	19	11
	6 mos	11 (57.9)	10 (90.9)
	12 mos	14 (73.7)	11 (100)
Renal	Baseline	0	105
	6 mos	0 (0)	20 (19)
	12 mos	0 (0)	29 (27.6)
Skin disease	Baseline	27	30
	6 mos	7 (25.9)	10 (33.3)
	12 mos	11 (40.7)	16 (53.3)
Serositis	Baseline	8	7
	6 mos	6 (75)	4 (57.1)
	12 mos	5 (62.5)	7 (100)
Immunological abnormalities	Baseline	45	85
	6 mos	11 (24.4)	15 (17.6)
	12 mos	12 (26.7)	15 (17.6)
Hematological abnormalities	Baseline	10	3
	6 mos	8 (80)	2 (66.7)
	12 mos	6 (60)	2 (66.7)